Expression and purification of dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris

Protein Expression and Purification

Volumn 23, Issue 1, 2001, Pages 84-96

  Bisht, Himani ^a   Chugh, Dipti A ^a   Swaminathan, Sathyamangalam ^a   Khanna, Navin ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Dengue envelope protein; Hepatitis B surface antigen; Pichia pastoris

Indexed keywords

ALCOHOL OXIDASE; AMINO ACID; CHIMERIC PROTEIN; DENGUE VIRUS TYPE 2; DENSITY GRADIENT CENTRIFUGATION; GENE FUSION; GENETIC REGULATION; HEPATITIS B ANTIGEN; HOST; MOLECULAR RECOGNITION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; VIRUS ENVELOPE PROTEIN;

PICHIA PASTORIS;

EID: 0034805367     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2001.1474     Document Type: Article

References (35)

1. Epidemic dengue/dengue haemorrhagic fever: A global public health problem in the 21st century
2. Dengue: The risk to developed and developing countries
3. Molecular biology of dengue viruses
4. Towards a new generation of flavivirus vaccines
5. Recombinant dengue vaccines
6. The dengue viruses
7. Flavivirus genome organization, expression and replication
8. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever
9. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection
10. Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice
11. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice
12. The production of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris
13. Evaluation of the protective efficacy of a recombinant dengue envelope B domain fusion protein against dengue 2 virus infection in mice
14. Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles
15. Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice
16. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice
17. Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 challenge
18. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation
19. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley Encephalitis virus elicit antiviral antibody
20. The Murray Valley Encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of the E glycoprotein
21. Heterologous protein expression in the methylotrophic yeast Pichia pastoris
22. Expression of the lacZ gene from two methanol-regulated promoters in Pichia pastoris
23. Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris
24. High level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris
25. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine
26. Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain)
27. Easy PCR screening of Pichia pastoris transformants
28. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
29. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
30. 2-glycoprotein I domain V by a recombinant Pichia pastoris: A simple system for the control of methanol concentration using a semiconductor gas sensor
31. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein
32. Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles
33. Recombinant hepatitis B surface antigen as a carrier of human immunodeficiency virus epitopes